NCT05089266 2023-07-17
Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors
Shanghai Cell Therapy Group Co.,Ltd
Phase 1 Unknown
Shanghai Cell Therapy Group Co.,Ltd
The Third Affiliated Hospital of Guangzhou Medical University
M.D. Anderson Cancer Center
Shenzhen BinDeBio Ltd.
Oslo University Hospital